A global clinical trial involving The Hospital for Sick Children (SickKids) has found that mavacamten—a heart medication ...

For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...

‘Major turning point’ as weight loss drugs to be prescribed to more NHS patients - Wegovy can now be prescribed for weight ...

Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular ...

In their analysis, the authors evaluated the effects of commonly used cardiovascular medications in patients with multiple myeloma. These widely prescribed drugs, used to manage high blood pressure, ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other ...

Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact on survival among people living with multiple myeloma, ...

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), or nonalcoholic fatty liver disease, has increased steadily over past decades. It now affects 38% of adults ...

Published March 18 in BMJ Medicine, the findings show that stopping GLP-1 medications has effects that extend beyond weight gain. The results highlight an increase in cardiovascular risk and reinforce ...

Commonly prescribed cardiovascular medications - such as statins, diuretics, and blood pressure drugs - appear to have little or no negative impact on survival among people living with multiple ...